James E. Tisdale PharmD, BCPS, FCCP, FAPhA, FAHAProfessor, College of Pharmacy, Purdue University; Adjunct Professor, School of Medicine, Indiana University, Indianapolis, Indiana
Dr. James E. Tisdale earned his Bachelor of Science in Pharmacy degree at the University of Manitoba and his Doctor of Pharmacy at the State University of New York at Buffalo. He completed a pharmacy practice residency at the University of Manitoba Health Sciences Centre and a postdoctoral fellowship in Cardiovascular Pharmacology & Therapeutics at Hartford Hospital and the University of Connecticut. From 1990-2002 he was Assistant/Associate Professor in the College of Pharmacy and Health Sciences at Wayne State University and Coordinator, Education and Training, Department of Pharmacy Services, Henry Ford Hospital in Detroit, MI. Currently, he is a Professor in the College of Pharmacy at Purdue University and Adjunct Professor, School of Medicine, Indiana University in Indianapolis, IN.
Dr. Tisdale’s research on the prevention and management of naturally occurring and drug-induced arrhythmias has resulted in > 140 journal articles, book chapters and abstracts. He is co-editor of the book, Drug-Induced Diseases: Prevention, Detection and Management, currently in its 2nd edition, with the 3rd edition in preparation. Dr. Tisdale is a Scientific Editor for the journal Pharmacotherapy.
From 2008-2009, Dr. Tisdale was Chair of the Clinical Sciences section, Academy of Pharmaceutical Research & Science, American Pharmacists Association. From 2009-2010, he served President of the American College of Clinical Pharmacy. Dr. Tisdale is a fellow of the American College of Clinical Pharmacy, the American Pharmacists Association, and the American Heart Association.
Recent Contributions to PracticeUpdate:
- Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
- Oral Inhalation Flecainide Acetate for Acute Conversion of Recent-Onset, Symptomatic AF to Sinus Rhythm
- Warfarin Use Is Associated With Progressive Coronary Arterial Calcification
- Drug–Drug Interactions With Statins and Select Agents Used in Cardiovascular Disease
- The Effectiveness of Pharmacist Interventions on Cardiovascular Risk